BOSULIF (bosutinib) tablet Health Professional Information

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

SUMMARY PRODUCT INFORMATION

§
Not commercially available in Canada

Route of Administration

Dosage Form / Strength

Clinically Relevant Nonmedicinal Ingredients

Oral

Tablets 100 mg, 400 mg§ and 500 mg

Coating:  iron oxide yellow (100 mg), iron oxide yellow and iron oxide red (400 mg), iron oxide red (500 mg).

Tablet:

For a complete listing see Dosage Forms, Composition and Packaging section.